nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC6A3—Parkinson's disease	0.51	0.656	CbGaD
Chlorphenamine—CYP2D6—Parkinson's disease	0.268	0.345	CbGaD
Chlorphenamine—SLC6A2—locus ceruleus—Parkinson's disease	0.00743	0.131	CbGeAlD
Chlorphenamine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00587	0.104	CbGeAlD
Chlorphenamine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00437	0.0772	CbGeAlD
Chlorphenamine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00395	0.0698	CbGeAlD
Chlorphenamine—SLC6A3—nerve—Parkinson's disease	0.00275	0.0487	CbGeAlD
Chlorphenamine—SLC6A2—nerve—Parkinson's disease	0.00222	0.0393	CbGeAlD
Chlorphenamine—SLC6A3—hindbrain—Parkinson's disease	0.00206	0.0365	CbGeAlD
Chlorphenamine—SLC6A4—hindbrain—Parkinson's disease	0.00189	0.0334	CbGeAlD
Chlorphenamine—SLC6A3—brainstem—Parkinson's disease	0.00118	0.0209	CbGeAlD
Chlorphenamine—SLC6A3—forebrain—Parkinson's disease	0.00114	0.0202	CbGeAlD
Chlorphenamine—SLC22A1—forebrain—Parkinson's disease	0.00112	0.0199	CbGeAlD
Chlorphenamine—SLC6A4—brainstem—Parkinson's disease	0.00108	0.0191	CbGeAlD
Chlorphenamine—SLC6A4—forebrain—Parkinson's disease	0.00105	0.0185	CbGeAlD
Chlorphenamine—SLC6A2—brainstem—Parkinson's disease	0.000953	0.0169	CbGeAlD
Chlorphenamine—SLC6A2—forebrain—Parkinson's disease	0.00092	0.0163	CbGeAlD
Chlorphenamine—CYP2D6—hindbrain—Parkinson's disease	0.000911	0.0161	CbGeAlD
Chlorphenamine—Captodiame—DRD3—Parkinson's disease	0.000855	0.128	CrCbGaD
Chlorphenamine—SLC6A3—midbrain—Parkinson's disease	0.000753	0.0133	CbGeAlD
Chlorphenamine—SLC6A3—spinal cord—Parkinson's disease	0.000735	0.013	CbGeAlD
Chlorphenamine—SLC6A4—midbrain—Parkinson's disease	0.00069	0.0122	CbGeAlD
Chlorphenamine—SLC6A4—spinal cord—Parkinson's disease	0.000673	0.0119	CbGeAlD
Chlorphenamine—SLC6A2—medulla oblongata—Parkinson's disease	0.000665	0.0118	CbGeAlD
Chlorphenamine—HRH1—forebrain—Parkinson's disease	0.000662	0.0117	CbGeAlD
Chlorphenamine—SLC6A3—head—Parkinson's disease	0.000653	0.0115	CbGeAlD
Chlorphenamine—SLC22A1—head—Parkinson's disease	0.000643	0.0114	CbGeAlD
Chlorphenamine—SLC6A3—nervous system—Parkinson's disease	0.000619	0.0109	CbGeAlD
Chlorphenamine—SLC22A1—nervous system—Parkinson's disease	0.00061	0.0108	CbGeAlD
Chlorphenamine—SLC6A4—head—Parkinson's disease	0.000598	0.0106	CbGeAlD
Chlorphenamine—SLC6A3—central nervous system—Parkinson's disease	0.000596	0.0105	CbGeAlD
Chlorphenamine—SLC22A1—central nervous system—Parkinson's disease	0.000587	0.0104	CbGeAlD
Chlorphenamine—SLC6A3—cerebellum—Parkinson's disease	0.000583	0.0103	CbGeAlD
Chlorphenamine—SLC6A4—nervous system—Parkinson's disease	0.000567	0.01	CbGeAlD
Chlorphenamine—SLC6A4—central nervous system—Parkinson's disease	0.000546	0.00966	CbGeAlD
Chlorphenamine—SLC6A2—head—Parkinson's disease	0.000527	0.00931	CbGeAlD
Chlorphenamine—CYP2D6—brainstem—Parkinson's disease	0.000522	0.00923	CbGeAlD
Chlorphenamine—CYP2D6—forebrain—Parkinson's disease	0.000504	0.00891	CbGeAlD
Chlorphenamine—SLC6A2—nervous system—Parkinson's disease	0.0005	0.00883	CbGeAlD
Chlorphenamine—SLC6A2—central nervous system—Parkinson's disease	0.000481	0.0085	CbGeAlD
Chlorphenamine—SLC6A3—brain—Parkinson's disease	0.000473	0.00837	CbGeAlD
Chlorphenamine—SLC22A1—brain—Parkinson's disease	0.000466	0.00824	CbGeAlD
Chlorphenamine—SLC6A4—brain—Parkinson's disease	0.000434	0.00767	CbGeAlD
Chlorphenamine—SLC6A2—brain—Parkinson's disease	0.000382	0.00675	CbGeAlD
Chlorphenamine—HRH1—head—Parkinson's disease	0.000379	0.0067	CbGeAlD
Chlorphenamine—Clomipramine—GSTP1—Parkinson's disease	0.000376	0.0564	CrCbGaD
Chlorphenamine—HRH1—nervous system—Parkinson's disease	0.00036	0.00635	CbGeAlD
Chlorphenamine—Mepyramine—CYP2D6—Parkinson's disease	0.00035	0.0526	CrCbGaD
Chlorphenamine—HRH1—central nervous system—Parkinson's disease	0.000346	0.00612	CbGeAlD
Chlorphenamine—Tripelennamine—CYP2D6—Parkinson's disease	0.000324	0.0487	CrCbGaD
Chlorphenamine—Carbinoxamine—CYP2E1—Parkinson's disease	0.000302	0.0453	CrCbGaD
Chlorphenamine—CYP2D6—head—Parkinson's disease	0.000289	0.0051	CbGeAlD
Chlorphenamine—Chlorprothixene—DRD3—Parkinson's disease	0.000288	0.0432	CrCbGaD
Chlorphenamine—Chlorprothixene—DRD1—Parkinson's disease	0.000283	0.0425	CrCbGaD
Chlorphenamine—CYP3A4—nervous system—Parkinson's disease	0.000278	0.00491	CbGeAlD
Chlorphenamine—HRH1—brain—Parkinson's disease	0.000275	0.00486	CbGeAlD
Chlorphenamine—CYP2D6—nervous system—Parkinson's disease	0.000274	0.00484	CbGeAlD
Chlorphenamine—CYP3A4—central nervous system—Parkinson's disease	0.000268	0.00473	CbGeAlD
Chlorphenamine—CYP2D6—central nervous system—Parkinson's disease	0.000263	0.00466	CbGeAlD
Chlorphenamine—Brompheniramine—CYP2E1—Parkinson's disease	0.000261	0.0392	CrCbGaD
Chlorphenamine—Tolterodine—CYP2D6—Parkinson's disease	0.000258	0.0388	CrCbGaD
Chlorphenamine—CYP2D6—cerebellum—Parkinson's disease	0.000257	0.00455	CbGeAlD
Chlorphenamine—Carbinoxamine—CYP2D6—Parkinson's disease	0.000222	0.0333	CrCbGaD
Chlorphenamine—Promazine—DRD1—Parkinson's disease	0.000221	0.0332	CrCbGaD
Chlorphenamine—Chlorpromazine—HTR7—Parkinson's disease	0.000211	0.0317	CrCbGaD
Chlorphenamine—CYP2D6—brain—Parkinson's disease	0.000209	0.0037	CbGeAlD
Chlorphenamine—Chlorprothixene—DRD2—Parkinson's disease	0.000199	0.0299	CrCbGaD
Chlorphenamine—Chlorpromazine—DRD3—Parkinson's disease	0.000198	0.0298	CrCbGaD
Chlorphenamine—Chlorpromazine—DRD1—Parkinson's disease	0.000195	0.0292	CrCbGaD
Chlorphenamine—Brompheniramine—CYP2D6—Parkinson's disease	0.000192	0.0288	CrCbGaD
Chlorphenamine—Orphenadrine—CYP2E1—Parkinson's disease	0.000165	0.0247	CrCbGaD
Chlorphenamine—Chlorpromazine—HTR1A—Parkinson's disease	0.000162	0.0243	CrCbGaD
Chlorphenamine—Promazine—DRD2—Parkinson's disease	0.000156	0.0234	CrCbGaD
Chlorphenamine—Clomipramine—HTR2A—Parkinson's disease	0.000155	0.0232	CrCbGaD
Chlorphenamine—Chlorprothixene—HTR2A—Parkinson's disease	0.000154	0.0231	CrCbGaD
Chlorphenamine—Clomipramine—CYP2D6—Parkinson's disease	0.000142	0.0212	CrCbGaD
Chlorphenamine—Chlorpromazine—DRD2—Parkinson's disease	0.000137	0.0206	CrCbGaD
Chlorphenamine—Chlorpromazine—CYP2E1—Parkinson's disease	0.000132	0.0198	CrCbGaD
Chlorphenamine—Diphenhydramine—CYP2D6—Parkinson's disease	0.000128	0.0192	CrCbGaD
Chlorphenamine—Promazine—HTR2A—Parkinson's disease	0.000121	0.0181	CrCbGaD
Chlorphenamine—Chlorpromazine—HTR2A—Parkinson's disease	0.000106	0.0159	CrCbGaD
Chlorphenamine—Clomipramine—ABCB1—Parkinson's disease	0.000101	0.0152	CrCbGaD
Chlorphenamine—Chlorprothixene—ABCB1—Parkinson's disease	0.000101	0.0151	CrCbGaD
Chlorphenamine—Chlorpromazine—CYP2D6—Parkinson's disease	9.71e-05	0.0146	CrCbGaD
Chlorphenamine—Chlorpromazine—ABCB1—Parkinson's disease	6.93e-05	0.0104	CrCbGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	5.31e-05	0.000335	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	5.24e-05	0.00033	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GBA—Parkinson's disease	5.19e-05	0.000327	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—FBP1—Parkinson's disease	5.19e-05	0.000327	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—DBH—Parkinson's disease	5.19e-05	0.000327	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—DBH—Parkinson's disease	5.19e-05	0.000327	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—FBP1—Parkinson's disease	5.19e-05	0.000327	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GBA—Parkinson's disease	5.19e-05	0.000327	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	5.08e-05	0.000321	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	4.98e-05	0.000314	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	4.98e-05	0.000314	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	4.97e-05	0.000313	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MCCC1—Parkinson's disease	4.95e-05	0.000312	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ND3—Parkinson's disease	4.95e-05	0.000312	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	4.9e-05	0.000309	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	4.86e-05	0.000306	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—DBH—Parkinson's disease	4.83e-05	0.000305	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GBA—Parkinson's disease	4.83e-05	0.000305	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—FBP1—Parkinson's disease	4.83e-05	0.000305	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	4.82e-05	0.000304	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.78e-05	0.000301	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.69e-05	0.000296	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	4.69e-05	0.000295	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—OMD—Parkinson's disease	4.66e-05	0.000294	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TALDO1—Parkinson's disease	4.66e-05	0.000294	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.62e-05	0.000291	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.62e-05	0.000291	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	4.58e-05	0.000289	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.53e-05	0.000286	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	4.51e-05	0.000285	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.5e-05	0.000284	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	4.42e-05	0.000279	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	4.42e-05	0.000279	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	4.42e-05	0.000278	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	4.41e-05	0.000278	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.35e-05	0.000274	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	4.29e-05	0.00027	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.23e-05	0.000266	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.22e-05	0.000266	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GCH1—Parkinson's disease	4.21e-05	0.000266	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.16e-05	0.000262	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	4.1e-05	0.000258	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.05e-05	0.000256	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	4.04e-05	0.000255	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	3.99e-05	0.000252	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.99e-05	0.000251	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.84e-05	0.000242	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—DDC—Parkinson's disease	3.81e-05	0.00024	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—DDC—Parkinson's disease	3.81e-05	0.00024	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.78e-05	0.000238	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—IL6—Parkinson's disease	3.78e-05	0.000238	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GBA—Parkinson's disease	3.75e-05	0.000237	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—DBH—Parkinson's disease	3.75e-05	0.000237	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—FBP1—Parkinson's disease	3.75e-05	0.000237	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.63e-05	0.000229	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTA4—Parkinson's disease	3.6e-05	0.000227	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTA4—Parkinson's disease	3.59e-05	0.000227	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.55e-05	0.000224	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—DDC—Parkinson's disease	3.55e-05	0.000224	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.53e-05	0.000223	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	3.53e-05	0.000223	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.53e-05	0.000222	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.52e-05	0.000222	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.52e-05	0.000222	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ND3—Parkinson's disease	3.52e-05	0.000222	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.5e-05	0.000221	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	3.49e-05	0.00022	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.49e-05	0.00022	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	3.49e-05	0.00022	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.38e-05	0.000213	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTA4—Parkinson's disease	3.35e-05	0.000211	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	3.35e-05	0.000211	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	3.33e-05	0.00021	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—OMD—Parkinson's disease	3.31e-05	0.000209	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.31e-05	0.000209	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	3.28e-05	0.000207	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.25e-05	0.000205	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	3.24e-05	0.000204	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	3.24e-05	0.000204	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	3.22e-05	0.000203	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—MAOB—Parkinson's disease	3.21e-05	0.000202	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—MAOB—Parkinson's disease	3.2e-05	0.000202	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.2e-05	0.000202	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.14e-05	0.000198	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	3.11e-05	0.000196	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	3.02e-05	0.000191	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PLA2G6—Parkinson's disease	3.02e-05	0.00019	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	3e-05	0.000189	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GCH1—Parkinson's disease	3e-05	0.000189	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—MAOB—Parkinson's disease	2.99e-05	0.000188	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	2.98e-05	0.000188	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	2.92e-05	0.000184	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.91e-05	0.000183	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PENK—Parkinson's disease	2.85e-05	0.00018	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MAG—Parkinson's disease	2.85e-05	0.00018	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	2.83e-05	0.000178	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	2.82e-05	0.000178	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	2.82e-05	0.000178	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—DDC—Parkinson's disease	2.76e-05	0.000174	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—DBH—Parkinson's disease	2.67e-05	0.000168	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.67e-05	0.000168	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GBA—Parkinson's disease	2.67e-05	0.000168	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	2.64e-05	0.000167	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	2.6e-05	0.000164	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTA4—Parkinson's disease	2.6e-05	0.000164	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	2.56e-05	0.000161	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	2.56e-05	0.000161	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	2.45e-05	0.000154	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	2.42e-05	0.000153	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	2.38e-05	0.00015	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	2.38e-05	0.00015	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	2.34e-05	0.000148	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CTGF—Parkinson's disease	2.34e-05	0.000148	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CTGF—Parkinson's disease	2.34e-05	0.000147	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MAOB—Parkinson's disease	2.32e-05	0.000146	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.3e-05	0.000145	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ND3—Parkinson's disease	2.3e-05	0.000145	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	2.26e-05	0.000142	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	2.22e-05	0.00014	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	2.18e-05	0.000138	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CTGF—Parkinson's disease	2.18e-05	0.000137	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	2.18e-05	0.000137	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—OMD—Parkinson's disease	2.17e-05	0.000137	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.17e-05	0.000137	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—NQO1—Parkinson's disease	2.16e-05	0.000136	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—NQO1—Parkinson's disease	2.15e-05	0.000136	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.15e-05	0.000135	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—TH—Parkinson's disease	2.13e-05	0.000134	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	2.12e-05	0.000134	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—TH—Parkinson's disease	2.12e-05	0.000134	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	2.06e-05	0.00013	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.05e-05	0.000129	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	2.05e-05	0.000129	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYCS—Parkinson's disease	2.04e-05	0.000129	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYCS—Parkinson's disease	2.04e-05	0.000128	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	2.03e-05	0.000128	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—NQO1—Parkinson's disease	2.01e-05	0.000127	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—TH—Parkinson's disease	1.98e-05	0.000125	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.97e-05	0.000124	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.96e-05	0.000124	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.96e-05	0.000123	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—INSR—Parkinson's disease	1.9e-05	0.00012	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYCS—Parkinson's disease	1.9e-05	0.00012	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.85e-05	0.000117	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—COMT—Parkinson's disease	1.81e-05	0.000114	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—COMT—Parkinson's disease	1.8e-05	0.000114	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTP1—Parkinson's disease	1.8e-05	0.000113	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTP1—Parkinson's disease	1.8e-05	0.000113	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—FGB—Parkinson's disease	1.8e-05	0.000113	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—MAOA—Parkinson's disease	1.79e-05	0.000113	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—MAOA—Parkinson's disease	1.79e-05	0.000113	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	1.79e-05	0.000113	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	1.79e-05	0.000113	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—HMOX1—Parkinson's disease	1.77e-05	0.000112	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—HMOX1—Parkinson's disease	1.77e-05	0.000112	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	1.76e-05	0.000111	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—DBH—Parkinson's disease	1.75e-05	0.00011	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.75e-05	0.00011	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GBA—Parkinson's disease	1.75e-05	0.00011	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	1.73e-05	0.000109	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	1.72e-05	0.000109	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ABCB1—Parkinson's disease	1.7e-05	0.000107	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ABCB1—Parkinson's disease	1.7e-05	0.000107	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CTGF—Parkinson's disease	1.69e-05	0.000107	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—COMT—Parkinson's disease	1.68e-05	0.000106	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTP1—Parkinson's disease	1.67e-05	0.000106	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	1.67e-05	0.000105	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—MAOA—Parkinson's disease	1.67e-05	0.000105	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.67e-05	0.000105	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTM1—Parkinson's disease	1.65e-05	0.000104	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—HMOX1—Parkinson's disease	1.65e-05	0.000104	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTM1—Parkinson's disease	1.65e-05	0.000104	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.65e-05	0.000104	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ABCB1—Parkinson's disease	1.58e-05	9.99e-05	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GPX1—Parkinson's disease	1.58e-05	9.98e-05	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GPX1—Parkinson's disease	1.58e-05	9.96e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	1.58e-05	9.94e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	1.56e-05	9.84e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—NQO1—Parkinson's disease	1.56e-05	9.83e-05	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTM1—Parkinson's disease	1.54e-05	9.7e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TH—Parkinson's disease	1.54e-05	9.69e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	1.51e-05	9.53e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	1.51e-05	9.53e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYCS—Parkinson's disease	1.48e-05	9.3e-05	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GPX1—Parkinson's disease	1.47e-05	9.29e-05	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—MTHFR—Parkinson's disease	1.46e-05	9.21e-05	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—MTHFR—Parkinson's disease	1.46e-05	9.2e-05	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—APOE—Parkinson's disease	1.36e-05	8.57e-05	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—MTHFR—Parkinson's disease	1.36e-05	8.57e-05	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—APOE—Parkinson's disease	1.36e-05	8.56e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—COMT—Parkinson's disease	1.31e-05	8.24e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.3e-05	8.2e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.3e-05	8.18e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.28e-05	8.08e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.28e-05	8.08e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.27e-05	7.98e-05	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—APOE—Parkinson's disease	1.27e-05	7.98e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.23e-05	7.76e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.22e-05	7.72e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.21e-05	7.63e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.21e-05	7.63e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.2e-05	7.59e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTM1—Parkinson's disease	1.19e-05	7.53e-05	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—INS—Parkinson's disease	1.16e-05	7.32e-05	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—INS—Parkinson's disease	1.16e-05	7.31e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.14e-05	7.21e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.12e-05	7.07e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—NGF—Parkinson's disease	1.11e-05	7.01e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.11e-05	6.99e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TH—Parkinson's disease	1.09e-05	6.89e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.09e-05	6.87e-05	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—INS—Parkinson's disease	1.08e-05	6.82e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.08e-05	6.8e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	1.06e-05	6.67e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.06e-05	6.66e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.05e-05	6.61e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—APOE—Parkinson's disease	9.84e-06	6.2e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—APOE—Parkinson's disease	9.83e-06	6.2e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—COMT—Parkinson's disease	9.29e-06	5.86e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	9.25e-06	5.83e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MAOA—Parkinson's disease	9.22e-06	5.82e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	9.12e-06	5.75e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	8.75e-06	5.52e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	8.5e-06	5.36e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—INS—Parkinson's disease	8.41e-06	5.3e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—INS—Parkinson's disease	8.4e-06	5.29e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GPX1—Parkinson's disease	8.14e-06	5.13e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.01e-06	5.05e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CTGF—Parkinson's disease	7.87e-06	4.96e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	7.51e-06	4.73e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	7.33e-06	4.62e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—NQO1—Parkinson's disease	7.25e-06	4.57e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TH—Parkinson's disease	7.14e-06	4.5e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—APOE—Parkinson's disease	6.99e-06	4.41e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYCS—Parkinson's disease	6.86e-06	4.32e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	6.26e-06	3.95e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	6.22e-06	3.92e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—COMT—Parkinson's disease	6.07e-06	3.83e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.05e-06	3.81e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.03e-06	3.8e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—INS—Parkinson's disease	5.97e-06	3.76e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	5.96e-06	3.76e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	5.75e-06	3.63e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.72e-06	3.61e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5.56e-06	3.5e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.32e-06	3.35e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.91e-06	3.1e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—APOE—Parkinson's disease	4.57e-06	2.88e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—INS—Parkinson's disease	3.9e-06	2.46e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL6—Parkinson's disease	3.67e-06	2.32e-05	CbGpPWpGaD
